SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001213900-23-084811
Filing Date
2023-11-08
Accepted
2023-11-08 17:05:26
Documents
7

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea187877-s1_inmedpharma.htm S-1 334977
2 OPINION OF NORTON ROSE FULBRIGHT CANADA LLP ea187877ex5-1_inmedpharma.htm EX-5.1 13600
3 CONSENT OF MARCUM LLP ea187877ex23-1_inmedpha.htm EX-23.1 2084
4 CONSENT OF KPMG LLP ea187877ex23-2_inmedpha.htm EX-23.2 2107
5 FILING FEE TABLE ea187877ex-fee_inmedpharma.htm EX-FILING FEES 16701
6 GRAPHIC image_001.jpg GRAPHIC 5644
7 GRAPHIC ex5-1_001.jpg GRAPHIC 3707
  Complete submission text file 0001213900-23-084811.txt   383605
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: S-1 | Act: 33 | File No.: 333-275410 | Film No.: 231389133
SIC: 2834 Pharmaceutical Preparations